Significant Benefits In Non-small-cell Lung Cancer From Customizing Erlotinib Treatment
September 15th, 2008
 Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.